Archive · 14 Nov 2025
Tata Memorial Study Reveals Radiation Therapy After Surgery Significantly Reduces Bladder Cancer Recurrence
Imagine a person has bladder cancer and needs surgery to remove it.
Even after surgery, there's a chance the cancer could come back in the same area.
Doctors in India did a big study with over 150 people to see if using X-rays, called radiation therapy, after surgery could help stop the cancer from returning.
They found that patients who got radiation therapy after their surgery had much less chance of the cancer coming back in the pelvic area.
This treatment was also safe and didn't cause extra problems.
It’s like giving an extra shield to protect that area.
This is important because when cancer comes back, it's often very hard to treat.
So, this study shows that adding radiation therapy to surgery is a good way to help patients stay healthier for longer and live better lives.
A large Indian study shows radiation therapy after bladder cancer surgery significantly reduces cancer recurrence.
The Bladder Adjuvant Radiotherapy (BART) trial is the largest randomized study of its kind, involving over 150 patients.
Results indicate a marked reduction in local cancer recurrences without an increase in side effects.
Radiation therapy is proposed as an important, safe, and effective treatment option for high-risk bladder cancer patients post-surgery.
The study highlights a potential improvement in disease-free survival, cancer-specific survival, and overall survival by 12-15% with radiotherapy.
- Who
- Researchers at Tata Memorial Centre (TMC) and other Indian cancer centers
- What
- Conducted the largest randomized trial showing radiation therapy after bladder cancer surgery reduces recurrence risk
- When
- The trial enrolled patients between 2016 and 2024, with findings presented subsequently.
- Where
- India (four cancer centers)
- Why
- To evaluate the role of radiation therapy in reducing the risk of local cancer recurrence after bladder cancer surgery, as smaller studies suggested a benefit but lacked high-level randomized evidence.
Radiation Therapy as Standard Adjuvant Treatment
Focus on Other Treatments like Immunotherapy
Effectiveness in Reducing Recurrence
Radiation Therapy as Standard Adjuvant Treatment
Adjuvant pelvic radiotherapy after surgery can substantially improve pelvic control without causing toxicity, particularly benefiting high-risk patients.
Focus on Other Treatments like Immunotherapy
Historically, local treatments like radiotherapy have been ignored because patients are often assumed to be destined for distant metastasis, with a greater focus on systemic treatments.
Comparison with Other Treatments
Radiation Therapy as Standard Adjuvant Treatment
Radiotherapy offers an immediately accessible and evidence-based way to improve outcomes compared to immunotherapy.
Focus on Other Treatments like Immunotherapy
The next stage of research should focus on integrating radiotherapy with immunotherapy, suggesting immunotherapy is a current alternative focus.
- Study Focus
- Bladder cancer recurrence after surgery
- Key Finding
- Radiation therapy after surgery significantly reduces local cancer recurrence
- Study Name
- Bladder Adjuvant Radiotherapy (BART) trial
- Number of Patients Enrolled
- Over 150
- Participating Centers
- Four cancer centers in India
- Trial Duration
- 2016-2024
- Conference Presentation
- Selected for plenary session of American Society for Radiation Oncology (ASTRO)